Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities-Reference-Cited by-同舟云学术

Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities

Published:2023-04 Issue:4 Volume:46 Page:327-333
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Bauchau Vincent,Davis Kourtney,Frise Sarah^ORCID,Jouquelet-Royer Corinne,Wilkins Jamie

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

https://link.springer.com/content/pdf/10.1007/s40264-023-01290-8.pdf

Reference17 articles.

1. Our World in Data. Coronavirus (COVID-19) Vaccinations. https://ourworldindata.org/covid-vaccinations. Accessed 9 Feb 2023.

2. SAGE Working Group on Vaccine Hesitancy Report of the SAGE Working Group on Vaccine Hesitancy. https://thecompassforsbc.org/sbcc-tools/report-sage-working-group-vaccine-hesitancy. Accessed 7 Fe 2023.

3. European Medicines Agency. Good Pharmacovigilance Practices. https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmacovigilance/good-pharmacovigilance-practices. Accessed 7 Feb 2023.

4. Verbeke R, Lentacker I, De Smedt SC, Dewitte H. The dawn of mRNA vaccines: the COVID-19 case. J Control Release. 2021;333:511–20.

5. Lundstrom K. Viral vectors for COVID-19 vaccine development. Viruses. 2021;13(2):317. https://doi.org/10.3390/v13020317.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Landscape review of active vaccine safety surveillance activities for COVID-19 vaccines globally;Vaccine: X;2024-06

2. Collaboration within the global vaccine safety surveillance ecosystem during the COVID-19 pandemic: lessons learnt and key recommendations from the COVAX Vaccine Safety Working Group;BMJ Global Health;2024-03

3. The role of real-world evidence for regulatory and public health decision-making for Accelerated Vaccine Deployment- a meeting report;Biologicals;2024-02